Get started
Author

Lilian Martins Arruda

Observed names: Arruda, Lilian Silva Martins De, Lilian Arruda, Lilian Silva Martins de Arruda
OpenAlex ID: A5023708293
Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer
2019 · Luana Carolina Ferreira Fiuza Silva, Lilian Silva Martins de Arruda, et al. · Einstein (São Paulo) · 14
PDF
Current scenario and future perspectives of clinical research in Brazil: a national survey
2023 · Heloisa Resende, Taiane F Rebelatto, et al. · ecancermedicalscience · 11
PDF
Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023
2024 · Heloisa Resende, Roberto J Arai, et al. · ecancermedicalscience · 3
PDF
Breaking through barriers: Unraveling challenges in clinical trial participation among oncologic patients in a developing country.
2024 · Erika Bushatsky, Andressa Liz Cândido, et al. · Journal of Clinical Oncology · 1
PDF
"Randomized, placebo-controlled, double-blind trial of (purified) dry extract of Paullinia cupana (guaraná) for chemoradiation-related fatigue and quality of life in patients with head and neck cancer.
2015 · Suelen Patrícia dos Santos Martins, Cynthia lemos Ferreira, et al. · Journal of Clinical Oncology · 1
Meta-analysis of EGFR TKI as maintenance therapy in non-small cell lung cancer (NSCLC).
2014 · Lilian Martins Arruda, Felipe Melo Cruz, et al. · Journal of Clinical Oncology · 1
A national survey of current scenario and future perspectives of cancer research in Brazil.
2023 · Heloisa Resende, Taiane Francieli Rebelatto, et al. · Journal of Clinical Oncology
Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer
2019 · Silva, Luana Carolina Ferreira Fiuza, Arruda, Lilian Silva Martins De, et al. · Figshare
Works count: 8
Citation count: 31
H-index: 3
I10-index: 2
Year
Topic
Type